Cancer dx collaborations pile up for Proteome Sciences
This article was originally published in Clinica
Executive Summary
Paving the way for future revenue growth, UK proteomics specialist Proteome Sciences has forged collaboration deals with two US research centres to develop new tests for the cancer market.